Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Chiara Di Tucci, Giulia Galati, Giulia Mattei, Valentina Bonanni, Oriana Capri, Renzo D’Amelio, Ludovico Muzii & Pierluigi Benedetti Panici. (2021) The role of alpha lipoic acid in female and male infertility: a systematic review. Gynecological Endocrinology 37:6, pages 497-505.
Read now
Read now
Franca Fruzzetti, Anna Capozzi, Alessandro Canu & Stefano Lello. (2019) Treatment with d-chiro-inositol and alpha lipoic acid in the management of polycystic ovary syndrome. Gynecological Endocrinology 35:6, pages 506-510.
Read now
Read now
Franca Fruzzetti, Daria Perini, Marinella Russo, Fiorella Bucci & Angiolo Gadducci. (2017) Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS). Gynecological Endocrinology 33:1, pages 39-42.
Read now
Read now
S. Khattab, I. A. Mohsen, I. Aboul Foutouh, H. S. Ashmawi, M. N. Mohsen, M. van Wely, F. van der Veen & M. Af. Youssef. (2011) Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study. Gynecological Endocrinology 27:10, pages 789-793.
Read now
Read now
Articles from other publishers (27)
Dario Rahelić & Zrinka Šakić. 2023. Metformin - A Prospective Alternative for the Treatment of Chronic Diseases. Metformin - A Prospective Alternative for the Treatment of Chronic Diseases.
Mirjana Šumarac-Dumanović, Danica Stamenković-Pejković, Danka Jeremić, Janko Dumanović, Vesna Mandić-Marković, Miloš Žarković & Dragan Micić. (2022) Age, Body Mass Index, and Waist-to-Hip Ratio Related Changes in Insulin Secretion and Insulin Sensitivity in Women with Polycystic Ovary Syndrome: Minimal Model Analyses. International Journal of Endocrinology 2022, pages 1-11.
Crossref
Crossref
O.M. Drapkina, O.T. Kim & V.A. Dadaeva. (2021) Obese patient safety: is it possible to predict the risks at all stages of medical care?. Profilakticheskaya meditsina 24:3, pages 87.
Crossref
Crossref
Daniel Mayrhofer, Marlene Hager, Katharina Walch, Stefan Ghobrial, Nina Rogenhofer, Rodrig Marculescu, Rudolf Seemann & Johannes Ott. (2020) The Prevalence and Impact of Polycystic Ovary Syndrome in Recurrent Miscarriage: A Retrospective Cohort Study and Meta-Analysis. Journal of Clinical Medicine 9:9, pages 2700.
Crossref
Crossref
Franca Fruzzetti, Elena Benelli, Tiziana Fidecicchi & Massimo Tonacchera. (2020) Clinical and Metabolic Effects of Alpha-Lipoic Acid Associated with Two Different Doses of Myo-Inositol in Women with Polycystic Ovary Syndrome. International Journal of Endocrinology 2020, pages 1-8.
Crossref
Crossref
В. Де Лео, А. Ла Марка & В. Каппеллі. (2019) Evaluation of the treatment with D-chiroinositol on levels of oxidative stress in pcos patients. Reproductive Endocrinology 0:49, pages 67-72.
Crossref
Crossref
Erica Silvestris, Giovanni de Pergola, Raffaele Rosania & Giuseppe Loverro. (2018) Obesity as disruptor of the female fertility. Reproductive Biology and Endocrinology 16:1.
Crossref
Crossref
Seyed Mojtaba Sohrevardi, Fahime Nosouhi, Saeed Hossein Khalilzade, Parichehr Kafaie, Mojgan Karimi-Zarchi, Iman Halvaei & Mehdi Mohsenzadeh. (2016) Evaluating the effect of insulin sensitizers metformin and pioglitazone alone and in combination on women with polycystic ovary syndrome: An RCT. International Journal of Reproductive BioMedicine 14:12, pages 743-754.
Crossref
Crossref
Xian-Ling Zeng, Ya-Fei Zhang, Quan Tian, Yan Xue & Rui-Fang An. (2016) Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome. Medicine 95:36, pages e4526.
Crossref
Crossref
Charles J. Glueck, Ping Wang, Jessica G. Woo, John A. Morrison, Philip R. Khoury & Stephen R. Daniels. (2015) Adolescent and Young Adult Female Determinants of Visceral Adipose Tissue at Ages 26-28 Years. The Journal of Pediatrics 166:4, pages 936-946.e3.
Crossref
Crossref
O. R. Grigoryan, E. V. Sheremetyeva & E. N. Andreeva. (2015) The use of the insulin sensitizer (metformin hydrochloride) in the treatment of infertility in patients with metabolic syndrome (a review). Problemy reproduktsii 21:3, pages 51.
Crossref
Crossref
Alexandra Bargiota & Evanthia Diamanti-Kandarakis. (2012) The effects of old, new and emerging medicines on metabolic aberrations in PCOS. Therapeutic Advances in Endocrinology and Metabolism 3:1, pages 27-47.
Crossref
Crossref
A. B. Motta. (2010) Report of the international symposium: polycystic ovary syndrome: first Latin-American consensus. International Journal of Clinical Practice 64:5, pages 544-557.
Crossref
Crossref
Charles J. Glueck, John A. Morrison, Naila Goldenberg & Ping Wang. (2009) Coronary heart disease risk factors in adult premenopausal white women with polycystic ovary syndrome compared with a healthy female population. Metabolism 58:5, pages 714-721.
Crossref
Crossref
C.J. Glueck, N. Goldenberg & P. Wang. (2009) Metformin-Diet Ameliorates Coronary Heart Disease Risk Factors and Facilitates Resumption of Regular Menses in Adolescents with Polycystic Ovary Syndrome. Journal of Pediatric Endocrinology and Metabolism 22:9.
Crossref
Crossref
Ephia YasminAdam H Balen. (2016) Management of Polycystic Ovary Syndrome. Women's Health 3:3, pages 355-367.
Crossref
Crossref
Paulina A. Essah & John E. Nestler. 2007. Androgen Excess Disorders in Women. Androgen Excess Disorders in Women
273
281
.
Charles J. Glueck, Dawit Aregawi, Mahlia Agloria, Magdalena Winiarska, Luann Sieve & Ping Wang. (2006) Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome. Metabolism 55:12, pages 1582-1589.
Crossref
Crossref
Charles J. Glueck, Karl C. Golnik, Dawit Aregawi, Naila Goldenberg, Luann Sieve & Ping Wang. (2006) Changes in weight, papilledema, headache, visual field, and life status in response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia. Translational Research 148:5, pages 215-222.
Crossref
Crossref
Wael Salameh, Jason P. Helliwell, Guang Han, Laron McPhaul & Omid Khorram. (2006) Expression of endometrial glycogen synthase kinase-3β protein throughout the menstrual cycle and its regulation by progesterone. MHR: Basic science of reproductive medicine 12:9, pages 543-549.
Crossref
Crossref
Charles J. Glueck, John A. Morrison, Lisa Aronson Friedman, Naila Goldenberg, Davis M. Stroop & Ping Wang. (2006) Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents. Metabolism 55:4, pages 508-514.
Crossref
Crossref
Charles J. Glueck, Luann Sieve, Binghua Zhu & Ping Wang. (2006) Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome. Metabolism 55:3, pages 345-352.
Crossref
Crossref
C.J. Glueck, D. Aregawi, M. Winiarska, M. Agioria, G. Luo, L. Sieve & P. Wang. (2006) Metformin-Diet Ameliorates Coronary Heart Disease Risk Factors and Facilitates Resumption of Regular Menses in Adolescents with Polycystic Ovary Syndrome. Journal of Pediatric Endocrinology and Metabolism 19:6.
Crossref
Crossref
M.A. Checa, A. Requena, C. Salvador, R. Tur, J. Callejo, J.J. Espinós, F. Fábregues & J. Herrero. (2005) Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome. Human Reproduction Update 11:4, pages 375-390.
Crossref
Crossref
Charles J. Glueck, Dawit Aregawi, Naila Goldenberg, Karl C. Golnik, Luann Sieve & Ping Wang. (2005) Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia. Journal of Laboratory and Clinical Medicine 145:2, pages 72-82.
Crossref
Crossref
Didem DERELI, Tugrul DERELI, Firat BAYRAKTAR, A. Gokhan OZGEN & Candeger YILMAZ. (2005) Endocrine and Metabolic Effects of Rosiglitazone in Non-obese Women with Polycystic Ovary Disease. Endocrine Journal 52:3, pages 299-308.
Crossref
Crossref
Naila Goldenberg, Charles J. Glueck, Matt Loftspring, Adam Sherman & Ping Wang. (2005) Metformin-diet benefits in women with polycystic ovary syndrome in the bottom and top quintiles for insulin resistance. Metabolism 54:1, pages 113-121.
Crossref
Crossref